The first paper for this workshop addresses some aspects of the formal distribution system of pharmaceuticals in South Asia and indicates some ways in which the ground situation departs from the requirements of the formal regulations. This paper addresses similar issues, but from a rather different angle. The consumption of pharmaceuticals in the global South has been increasing, but there are varying interpretations of the reasons behind this. One perspective, for instance, suggests that the social and economic changes being wrought by processes of globalisation have generated ailments for which people seek relief and that is reflected in increasing demands for pharmaceuticals: here, pharmaceutical companies are simply meeting those demands. A rather different reading suggests that drug companies have been actively and successfully creating demands for their products by extending the psychiatric disease classifications used by doctors and potential patients/consumers and actively marketing the antidotes that deal with these new found ailments.
|Publisher||University of Edinburgh|
|Number of pages||23|
|Publication status||Published - 3 Jul 2007|